A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here
Sunday, 6 October 2013
* Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents (Court of Justice of the European Union)
* Actavis Group PTC EHF v Sanofi (Patents Court, England and Wales)
* AstraZeneca AB v Comptroller-General of Patents (Patents Court, England and Wales)
* GlaxoSmithKline Biologicals SA v Comptroller-General of Patents (Patents Court, England and Wales).
The RPC is an official law report, published since 1884 and suitable for citation in UK litigation.